FSS | PUBLICATIONS
PUBLICATIONS
Explore articles based on work undertaken by Frontier Science Scotland
The HERA Trial: The Benefits of Trastuzumab by Degree of HER2 amplification
An article in the JCO shows that the degree of HER2 amplification does not influence prognosis or benefit from adjuvant trastuzumab in patients treated with prior adjuvant chemotherapy.
The HERA Trial: Adjuvant trastuzumab therapy reduces the risk of relapse across subgroups
The Annals of Oncology presents the magnitude of trastuzumab effects within patient subgroups in the HERA trial.
The HERA Trial: Results of the First Planned Interim Analysis
An article in the New England Journal of Medicine reporting on the results of the first, planned interim analysis of the HERA Trial.